A virtual conference fully dedicated to furthering the understanding of Value Added Medicine development, approval and commercialization 

Value Added Medicines are:

>60% 

OF ALL NEW DRUG APPROVALS

~20% - 90%

LESS COSTLY TO DEVELOP

VAM Week is a novel approach to expanding awareness and understanding of Value Added Medicines

Hear from and interact with speakers from the FDA, Industry and Suppliers as they discuss important topics and areas in the development, approval and commercialization of medications utilizing FDA's 505(b)(2) Pathway.

Review Agenda

---

Registration Types

Review the agenda, choose a registration type, receive attendance information and codes

Single Session Registration

Use the Single Session for each sessions you would like to register for up to up to 4 separate sessions. Before Value Added Medicines (VAM) Week you will receive email invitations for each session. Please note when choosing multiple sessions you are not limited to one track and may choose sessions from either track.

5 Session Registration

Purchase 5 sessions and save 20% off a single session registration. Before Value Added Medicines Week you will receive Zoom invitations with admission links to your selected sessions. Please note when choosing multiple sessions you are not limited to one track and may choose sessions from either track.

Full Program Registration

Register for the full program and save 30% over the single session registration price. Before Value Added Medicines (VAM) Week you will receive email invitations for each session.

Sign up for 1 session for $50
Or as many sessions as you want
Sign up for 5 sessions and receive a 20% discount
Sign up for all 10 sessions and receive a 30% discount
Sign up 5 people for all 10 sessions and receive a astounding 50% discount 

repurposed

Identifying a new use for an already approved pharmaceutical product that is outside the scope of the original medical indication

reformulated

Developing a different formulation for an already approved pharmaceutical product 

repositioned

Moving an existing and marketed pharmaceutical product from one regulatory class to another 

reauthorized

Gaining authorization in the US for a pharmaceutical product already in use in another ex-US market.